| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.064 | 0.3 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |